| Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, ... Jama 318 (9), 825-835, 2017 | 449 | 2017 |
| Prospective evaluation of germline alterations in patients with exocrine pancreatic neoplasms MA Lowery, W Wong, EJ Jordan, JW Lee, Y Kemel, J Vijai, D Mandelker, ... JNCI: Journal of the National Cancer Institute 110 (10), 1067-1074, 2018 | 208 | 2018 |
| The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk TP Slavin, KN Maxwell, J Lilyquist, J Vijai, SL Neuhausen, SN Hart, ... NPJ breast cancer 3 (1), 22, 2017 | 145 | 2017 |
| Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer M Kara N, H Steven N, J Vijai, KA Schrader, TP Slavin, T Thomas, ... The American Journal of Human Genetics 98 (5), 801–817, 2016 | 126 | 2016 |
| Cancer susceptibility mutations in patients with urothelial malignancies MI Carlo, V Ravichandran, P Srinavasan, C Bandlamudi, Y Kemel, ... Journal of Clinical Oncology 38 (5), 406, 2020 | 77 | 2020 |
| Cascading after peridiagnostic cancer genetic testing: an alternative to population-based screening K Offit, KA Tkachuk, ZK Stadler, MF Walsh, H Diaz-Zabala, JD Levin, ... Journal of Clinical Oncology 38 (13), 1398, 2020 | 75 | 2020 |
| A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer J Vijai, S Topka, D Villano, V Ravichandran, KN Maxwell, A Maria, ... Cancer discovery 6 (11), 1267-1275, 2016 | 49 | 2016 |
| Toward automation of germline variant curation in clinical cancer genetics V Ravichandran, Z Shameer, Y Kemel, M Walsh, K Cadoo, S Lipkin, ... Genetics In Medicine, 2019 | 32 | 2019 |
| Prevalence of germline alterations on targeted tumor-normal sequencing of esophagogastric cancer GY Ku, Y Kemel, SB Maron, JF Chou, V Ravichandran, Z Shameer, ... JAMA Network Open 4 (7), e2114753-e2114753, 2021 | 19 | 2021 |
| Mutation rates in cancer susceptibility genes in patients with breast cancer with multiple primary cancers KN Maxwell, BM Wenz, A Kulkarni, B Wubbenhorst, K D’Andrea, ... JCO Precision Oncology 4, 916-925, 2020 | 16 | 2020 |
| Targeting germline-and tumor-associated nucleotide excision repair defects in cancer S Topka, Z Steinsnyder, V Ravichandran, K Tkachuk, Y Kemel, ... Clinical Cancer Research 27 (7), 1997-2010, 2021 | 14 | 2021 |
| Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer KA Cadoo, DL Mandelker, S Mukherjee, C Stewart, D DeLair, ... JCO precision oncology 3, 1-15, 2019 | 14 | 2019 |
| Multiple primary cancers in patients undergoing tumor-normal sequencing define novel associations YL Liu, KA Cadoo, S Mukherjee, A Khurram, K Tkachuk, Y Kemel, A Maio, ... Cancer Epidemiology, Biomarkers & Prevention 31 (2), 362-371, 2022 | 13 | 2022 |
| Genetically determined height and risk of non-Hodgkin lymphoma A Moore, E Kane, Z Wang, OA Panagiotou, LR Teras, A Monnereau, ... Frontiers in oncology 9, 1539, 2020 | 10 | 2020 |
| NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects S Belhadj, A Khurram, C Bandlamudi, G Palou-Márquez, V Ravichandran, ... Clinical Cancer Research 29 (2), 422-431, 2023 | 8 | 2023 |
| The serum protein profile of early parity which induces protection against breast cancer CG Bracamontes, R Lopez-Valdez, R Subramani, A Arumugam, S Nandy, ... Oncotarget 7 (50), 82538, 2016 | 7 | 2016 |
| A breast tissue protein expression profile contributing to early parity-induced protection against breast cancer CM Gutierrez, R Lopez-Valdez, R Subramani, A Arumugam, S Nandy, ... Cellular Physiology and Biochemistry 37 (5), 1671-1685, 2015 | 7 | 2015 |
| The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk. NPJ Breast Cancer. 2017; 3: 22 TP Slavin, KN Maxwell, J Lilyquist, J Vijai, SL Neuhausen, SN Hart, ... doi. org/10.1038/s41523-017-0024-8, 2017 | 6* | 2017 |
| Collaborative science in the next-generation sequencing era: a viewpoint on how to combine exome sequencing data across sites to identify novel disease susceptibility genes SN Hart, KN Maxwell, T Thomas, V Ravichandran, B Wubberhorst, ... Briefings in bioinformatics 17 (4), 672-677, 2016 | 6 | 2016 |
| Response to immune checkpoint blockade in patients with microsatellite instable and high tumor mutational burden prostate cancer AT Lenis, V Ravichandran, H Truong, P Reisz, B Nweji, K Autio, M Morris, ... JOURNAL OF UROLOGY 206, E411-E411, 2021 | 5 | 2021 |
Kenneth OffitMemorial Sloan Kettering Cancer CenterZweryfikowany adres z mskcc.org
